Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Capital Expenditures (2025 - 2026)

Updated

Analysis

Kardigan (KARD) Capital Expenditures (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 1.36 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 301.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 237.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 573.00 Mn
10 Kardigan 1.29 Bn -398.44 Mn - -4.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -4.70 Mn
Jun 30, 2026 3.26 Mn
Mar 31, 2026 -1.17 Mn
Jun 30, 2025 3.10 Mn
Mar 31, 2025 -542,000.00
API Access

Kardigan Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KARD&period=max&api_key=YOUR_API_KEY